Abbott Labs shares fall as earnings beat offset by Exact Sciences acquisition drag
96,685 Shares in Exact Sciences Corporation $EXAS Purchased by Capricorn Fund Managers Ltd
Exact Sciences Corporation $EXAS Shares Sold by Exchange Traded Concepts LLC
FNY Investment Advisers LLC Buys Shares of 28,500 Exact Sciences Corporation $EXAS
Banque Pictet & Cie SA Lowers Position in Exact Sciences Corporation $EXAS
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
Bridgefront Capital LLC Buys Shares of 11,994 Exact Sciences Corporation $EXAS
ArrowMark Colorado Holdings LLC Purchases 113,603 Shares of Exact Sciences Corporation $EXAS
Exact Sciences Corporation $EXAS Shares Bought by Dimensional Fund Advisors LP
Exact Sciences (EXAS) is a Top-Ranked Momentum Stock: Should You Buy?
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
DNB Asset Management AS Raises Position in Exact Sciences Corporation $EXAS
Exact Sciences Stockholders Approve Acquisition by Abbott
Here's Why Exact Sciences (EXAS) is a Strong Momentum Stock
Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up
Aberdeen Group plc Increases Stock Position in Exact Sciences Corporation $EXAS
Paul Tudor Jones Makes Significant Moves with iShares Core S&P 500 ETF
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
George Soros Reduces Stake in Smurfit WestRock PLC by 68.99%
Exact Sciences Corporation $EXAS Shares Sold by AlphaQuest LLC
Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Market Today: AI Fears Rattle Stocks; CPI Cools, Rivian Pops
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
Alger Mid Cap 40 ETF Q4 2025 Portfolio Update
Baron Opportunity Fund Q4 2025 Portfolio Activity
Allianz Asset Management GmbH Makes New Investment in Exact Sciences Corporation $EXAS
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences' '746 Patent
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
Oncotype DX Breast Recurrence Score® Test Surpasses 2 Million Patients Worldwide
Alger Small Cap Focus Fund Q4 2025 Portfolio Update
EXEL vs. EXAS: Which Stock Is the Better Value Option?
Alger Small Cap Growth Fund Q4 2025 Portfolio Update
Briacell Therap (NASDAQ:BCTX) versus Exact Sciences (NASDAQ:EXAS) Head-To-Head Survey
Small-Cap Growth Without Dividends: What NUSC's 1.4 Beta Really Costs Investors
Alger Mid Cap Focus Fund Q4 2025 Portfolio Update
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More
Exact Sciences Corporation $EXAS Stock Position Boosted by Massachusetts Financial Services Co. MA
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims
Should You Continue to Hold EXAS Stock in Your Portfolio Now?
Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc
Bamco Inc. NY Boosts Stock Holdings in Exact Sciences Corporation $EXAS
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
First Trust Advisors LP Trims Stake in Exact Sciences Corporation $EXAS
Baird Financial Group Inc. Sells 30,218 Shares of Exact Sciences Corporation $EXAS
Fisher Asset Management LLC Sells 27,925 Shares of Exact Sciences Corporation $EXAS
Why Is Exact Sciences (EXAS) Up 45.4% Since Last Earnings Report?